Andrew Cuthbertson
Director/Board Member presso ZENYTH THERAPEUTICS LIMITED
Patrimonio netto: 13 M $ in data 31/03/2024
Profilo
Attualmente, Andrew Cuthbertson occupa la posizione di Chief Scientific Officer & Executive Director presso CSL Ltd. e Chief Scientific Officer di CSL Behring LLC (una filiale di CSL Ltd.). Fa anche parte del consiglio di amministrazione di CSL Innovation Pty Ltd., Centre for Eye Research Australia e Grattan Institute ed è membro del Consiglio dell'Università di Melbourne. Andrew Cuthbertson ha precedentemente occupato la posizione di Senior Scientist presso Genentech, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CSL LIMITED
0.01% | 16/02/2024 | 70 391 ( 0.01% ) | 13 M $ | 31/03/2024 |
Posizioni attive di Andrew Cuthbertson
| Società | Posizione | Inizio |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - |
| CSL LIMITED | Director/Board Member | 17/10/2018 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Director/Board Member | 01/01/2018 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | 01/01/2016 |
| Centre for Eye Research Australia | Director/Board Member | 01/03/2017 |
Grattan Institute
 Grattan Institute Miscellaneous Commercial ServicesCommercial Services Grattan Institute develops public policy programs. The private company is based in Carlton, Australia. The CEO of the Australian company is John Daley. | Director/Board Member | 01/01/2019 |
Precedenti posizioni note di Andrew Cuthbertson
| Società | Posizione | Fine |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1997 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CSL LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
| Centre for Eye Research Australia | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Grattan Institute develops public policy programs. The private company is based in Carlton, Australia. The CEO of the Australian company is John Daley. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Cuthbertson
